Home›People›Gregory Hebrank
GH

Gregory Hebrank

Executive officer and director at Telemachus Therapeutics, Inc., a pharmaceutical startup

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Oct 28, 2026·Suggest an edit

About Gregory Hebrank

Gregory Hebrank is an executive officer and a director of Telemachus Therapeutics, Inc. He is also the company's secretary. Telemachus is a pharmaceutical startup incorporated in Delaware in 2026. It plans to support therapeutic research with well-documented datasets and reproducible computational analysis. Its direction also covers cloud-based analysis of research data.

Experience

This experience comes from official bios, from Gregory Hebrank's profile and from SEC filings. For roles taken from filings, the years are when the filings name Gregory Hebrank in the role, so the role may have started earlier or lasted longer.

Telemachus Therapeutics, Inc. Current
Executive Officer & Director
2026 – Present · Wexford, PA
A pharmaceutical startup that plans to keep context and limits attached to research data used in therapeutic decisions.
Biohaven Current
Advisor, Clinical & Discovery
2022 – Present
Knopp Biosciences LLC
Executive Vice President, Co-Founder
2004 – 2022
University of Pittsburgh School of Medicine
Resident Physician
1982 – 1986

Key Colleagues at Startups

The people Gregory Hebrank works with at each company, as listed on that company's latest Form D.

Telemachus Therapeutics, Inc. · Form D/A, Oct 28, 2026
MB
Michael Bozik
Executive Officer & Director

Gregory Hebrank in the News

Sources

  1. SECTelemachus Therapeutics, Inc. Form D/A, filed Oct 28, 2026